| Disease | neutropenia |
| Comorbidity | C0007131|nsclc |
| Sentences | 1 |
| PubMedID- 26448029 | The present meta-analysis suggested that erlotinib could decrease the incidence of neutropenia and leukopenia in patients with advanced nsclc undergoing erlotinib regardless of whether combined with ct or not. |
Page: 1